Bio-Works Technologies AB (publ) announced that effective May 17, 2024, Lone Carlbom has assumed the role of CEO of the company. Concurrently, the company's CEO to date, Jonathan Royce, has resigned from his position in consultation with Bio-Works? Board of Directors, effective immediately.

In line with the CEO transition, Bio-Works? management team is intended to be reorganized with the following positions: Arne Hauge, CFO and Head of Support Functions, Maria Åberg, Head of Production, Silvia Hellström, Head of Quality Assurance, Lone Carlbom will continue to oversee Product Management and R & D, A new Head of Sales will join the management team shortly. Lone Carlbom brings over 25 years of experience in leadership roles within the Life Sciences and Biotech industries, with expertise in product management, technical support, and sales.

Previously, she held the position of Head of Chromatography Resines and BioProcess Equipment at GE Healthcare Life Sciences (now Cytiva). Additionally, she has served as a consultant in change management and organizational development.